Ralliant (NYSE:RAL) Rating Increased to Hold at Zacks Research

Ralliant (NYSE:RAL) was upgraded by Zacks Research from a “strong sell” rating to a “hold” rating in a report released on Monday,Zacks.com reports.

A number of other equities research analysts have also weighed in on the stock. Vertical Research upgraded shares of Ralliant from a “hold” rating to a “buy” rating and set a $45.00 price objective for the company in a report on Friday, February 6th. Barclays decreased their price objective on shares of Ralliant from $60.00 to $52.00 and set an “overweight” rating for the company in a report on Monday, February 9th. Weiss Ratings lowered shares of Ralliant from a “hold (c)” rating to a “sell (d)” rating in a report on Thursday, February 5th. Royal Bank Of Canada decreased their price objective on shares of Ralliant from $52.00 to $41.00 and set a “sector perform” rating for the company in a report on Friday, February 6th. Finally, Citigroup reduced their price target on shares of Ralliant from $61.00 to $51.00 and set a “buy” rating for the company in a report on Friday, February 6th. Seven analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $50.50.

Ralliant Trading Down 0.4%

Shares of RAL opened at $46.54 on Monday. Ralliant has a 1-year low of $37.27 and a 1-year high of $57.02. The company has a 50-day moving average of $43.69 and a 200 day moving average of $46.76. The firm has a market capitalization of $5.20 billion and a price-to-earnings ratio of 23.74. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.84 and a quick ratio of 0.58.

Ralliant (NYSE:RAL) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $0.69 earnings per share for the quarter, beating analysts’ consensus estimates of $0.67 by $0.02. The company had revenue of $554.60 million for the quarter, compared to the consensus estimate of $543.04 million. The company’s revenue for the quarter was up 1.2% on a year-over-year basis. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Insiders Place Their Bets

In other Ralliant news, SVP Amir A. Kazmi purchased 2,545 shares of Ralliant stock in a transaction dated Friday, February 6th. The stock was acquired at an average price of $39.27 per share, for a total transaction of $99,942.15. Following the acquisition, the senior vice president owned 39,699 shares in the company, valued at $1,558,979.73. This trade represents a 6.85% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Karen M. Bick sold 2,530 shares of the business’s stock in a transaction dated Thursday, March 5th. The shares were sold at an average price of $46.50, for a total transaction of $117,645.00. Following the completion of the sale, the senior vice president owned 42,652 shares of the company’s stock, valued at approximately $1,983,318. This represents a 5.60% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have purchased 8,145 shares of company stock worth $332,233.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. Phocas Financial Corp. raised its stake in shares of Ralliant by 81.2% during the 4th quarter. Phocas Financial Corp. now owns 157,116 shares of the company’s stock worth $7,999,000 after acquiring an additional 70,403 shares in the last quarter. Vanguard Group Inc. raised its stake in shares of Ralliant by 10.7% during the 3rd quarter. Vanguard Group Inc. now owns 14,589,423 shares of the company’s stock worth $637,995,000 after acquiring an additional 1,415,327 shares in the last quarter. Welch & Forbes LLC bought a new position in shares of Ralliant during the 3rd quarter worth approximately $854,000. SG Capital Management LLC bought a new position in shares of Ralliant during the 3rd quarter worth approximately $8,139,000. Finally, Allspring Global Investments Holdings LLC raised its stake in shares of Ralliant by 5,269.9% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 317,038 shares of the company’s stock worth $14,000,000 after acquiring an additional 311,134 shares in the last quarter.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.